Sexually Transmitted Diseases Information for Researchers

Image of syphilis bacteria

Treponema pallidum, the bacteria that cause syphilis.

Credit
NIAID

Treponema pallidum, the bacteria that cause syphilis.

Credit: NIAID

Sexually transmitted diseases (STDs), or sexually transmitted infections (STIs), are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS biologically and epidemiologically. The ultimate objective of NIAID-supported research is to develop effective prevention and treatment approaches to control STDs.

Funding Opportunities

NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential funding for STD/STI research.

Program Officers

For contact information, search the NIH Enterprise Directory.

  • Dr. Eleanore Chuang, STI Clinical Research Program Officer
  • Dr. Thomas Hiltke, STIs Section Chief, STI Vaccines and Therapeutics Program Officer
  • Kimberly Murphy, Product Development Project Manager for STIs
  • Dr. Leah Vincent, STIs Basic Research Program Officer
  • Peter Wolff, Clinical Trials Specialist

Search our funding opportunities for STD-related grants

Connect With Other Researchers

Researchers at NIAID

Much of the STD research ongoing at NIAID takes place in these laboratories:

Laboratory of Immunoregulation

Laboratory of Infectious Diseases

Laboratory of Viral Diseases

Laboratory of Bacteriology

Laboratory of Clinical Immunology and Microbiology

Social Media

Resources for Researchers

You may request services if you are an investigator in academia, a not-for-profit organization, industry, or government in the United States or worldwide. You need not be a grantee of NIAID or another National Institutes of Health Institute or Center. Look to each resource for further eligibility information.


See a full list of resources for STD researchers

Meetings

Past Meetings

Current Challenges in Evaluating Antimicrobials for Urogenital Gonorrhea
Experts Collaborate to Design Thorough and Effective Future Trials
February 5-6, 2019

Content last reviewed on